Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective

Ke Wang1, Hiroaki Yamamoto, Jennie R Chin

  • 1Department of Medicine, University of California, San Francisco, CA 94143, USA.

Insights

Epidermal growth factor receptor (EGFR) signaling is crucial for bone development. EGFR deficiency in mice led to delayed ossification and abnormal growth plate development, impacting osteoclast formation.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Molecular Biology

Background:

  • Epidermal growth factor receptor (EGFR) signaling regulates critical cellular functions like proliferation, differentiation, motility, and survival.
  • EGFR signaling is vital for the development of various tissues, including skin, lungs, intestines, and the craniofacial skeleton.

Purpose of the Study:

  • To elucidate the role of EGFR signaling in endochondral ossification and long bone development.

Main Methods:

  • Analysis of long bone development in EGFR-deficient mice.
  • Assessment of osteoclast and osteoblast recruitment and activity.
  • Investigation of matrix metalloproteinase expression.
  • Evaluation of EGFR expression in osteoclasts.
  • Inhibition of EGFR tyrosine kinase activity in cultured bone marrow cells.

Main Results:

  • EGFR deficiency resulted in delayed primary ossification of the cartilage anlage.
  • Osteoclast and osteoblast recruitment was delayed in EGFR-deficient mice.
  • Growth plate ossification was abnormal, characterized by expanded hypertrophic cartilage and reduced bony trabeculae.
  • Delayed osteoclast recruitment was not linked to insufficient matrix metalloproteinase-9 expression.
  • EGFR expression in osteoclasts suggests direct ligand action on osteoclast formation and/or function.
  • Inhibition of EGFR tyrosine kinase activity reduced osteoclast generation from bone marrow cells.

Conclusions:

  • EGFR signaling plays a significant role in regulating endochondral ossification and long bone development.
  • EGFR signaling directly influences osteoclast formation and/or function.
  • Targeting EGFR signaling may offer therapeutic potential for bone development disorders.